LUNG THERAPEUTICS
Lung Therapeutics is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. Current efforts are focused on a severe complication of pneumonia, called loculated pleural effusion, a debilitating condition where fluid has built up in the chest cavity surrounding the lungs and fibrinous scar tissue in the pleural cavity blocks fluid drainage. Their first product, LTI-01 (single chain urokinase plasminogen activator, or scuPA), i... s being studied for safe clearance of fibrinous scar tissue in patients with loculated pleural effusion. By clearing the fibrinous buildup pharmaceutically, the clinical pathway for these patients is significantly improved, enabling simple draining of pleural fluid without surgery. Their longer-term efforts will target improvement of clinical pathways for Acute Lung Injury, Idiopathic Pulmonary Fibrosis and other disease conditions.
LUNG THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.lungtx.com
Total Employee:
11+
Status:
Active
Contact:
737-802-1989
Email Addresses:
[email protected]
Total Funding:
53.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Euro
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
O'Dell Family Chiropractic
O'Dell Family Chiropractic provide chiropractic treatments tor a range of health conditions.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bios Partners
Bios Partners investment in Series C - Lung Therapeutics
Bios Partners
Bios Partners investment in Series B - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Series B - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Series A - Lung Therapeutics
Texas Venture Labs
Texas Venture Labs investment in Non Equity Assistance - Lung Therapeutics
UT Horizon Fund
UT Horizon Fund investment in Convertible Note - Lung Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-13 | Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development |
Official Site Inspections
http://www.lungtx.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Lung Therapeutics"
Board of Directors - Lung Therapeutics
He has served on the boards of the California Life Sciences Association, Rx&D, an association of Canada’s research-based pharmaceutical companies, and PHenomenal Hope, an organization focused on funding research and patient …See details»
Management Team - Lung Therapeutics
Brian Windsor, Ph.D. Chief Executive Officer. Dr. Brian Windsor has served as President and CEO of Lung Therapeutics since July of 2013. He has spent the last 20 years in the formation and management of life science companies and …See details»
Lung Therapeutics - Overview, News & Similar companies
Jul 13, 2021 Lung Therapeutics contact info: Phone number: (737) 802-1979 Website: www.lungtx.com What does Lung Therapeutics do? Headquartered in Austin, Texas, Lung …See details»
Lung Therapeutics Company Profile | Management and Employees …
Www.lungtx.com . Lung Therapeutics Profile and History. Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage leading …See details»
Lung Therapeutics - Crunchbase Company Profile
Organization. Lung Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 737-802-1989; Lung Therapeutics is a …See details»
Lung Therapeutics Company Profile 2024: Valuation, Investors ...
Lung Therapeutics General Information Description. Developer of novel peptide drugs intended to facilitate treatments for fibrosis and lung conditions. The company's drugs trigger both survival …See details»
Company Information - RocketReach
Lung Therapeutics, Inc. employs 20 employees. The Lung Therapeutics, Inc. management team includes Brian Windsor (CEO), Sharon Morriss (SVP, Clinical Development), and Matt Karpen …See details»
Lung Therapeutics CEO and Key Executive Team | Craft.co
Lung Therapeutics's Chief Executive Officer, Director is Brian Windsor. Other executives include Charles Garner, Chief Financial Officer; William C. Fairey, Director and 7 others. See the full …See details»
Lung Therapeutics: Employee Directory | ZoomInfo.com
Lung Therapeutics Contact Info: Phone number: (737) 802-1979 Website: www.lungtx.com What does Lung Therapeutics do? Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a …See details»
Lung Therapeutics - Craft
Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease. Its two lead drug candidates are LTI-01, a pro-enzyme for …See details»
Lung Therapeutics, Inc. - Employees, Contact info, Overview - Wiza
May 1, 2024 You may visit their official website at https://lungtx.com. What's the official twitter of Lung Therapeutics, Inc. The twitter username of Lung Therapeutics, Inc. is @lung_tx. Find …See details»
Brian Windsor Email & Phone number - ZoomInfo
Brian Windsor contact details: Email address: b***@lungtx.com Phone number: (737) ***-**** Who is Brian Windsor? Dr. Brian Windsor has served as President and CEO of Lung Therapeutics …See details»
Austin Texas based Lung Therapeutics is raising ... - intelligence360
Apr 27, 2022 Austin, TX - According to filings with the U.S. Securities and Exchange Commission, Lung Therapeutics is raising $15,000,000.00 in new funding. Sources indicate as …See details»
Lung Therapeutics, Inc. | Austin TX - Facebook
Lung Therapeutics, Inc., Austin, Texas. 806 likes · 6 talking about this. Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lunSee details»
Press Releases - Lung Therapeutics
Feb 4, 2019 The company’s second drug candidate, LTI-03, is in development for Idiopathic Pulmonary Fibrosis and is ready to enter clinical development. For more information, visit …See details»
lungtx.com: Revenue, Competitors, Alternatives
Lungtx.com's estimated annual revenue is currently $3.4M per year. lungtx.com 's estimated revenue per employee is $ 155,000Employee Data. lungtx.com has 22 Employees. …See details»
Posters & Publications :: Lung Therapeutics - lungtx.com
Nov 9, 2017 3801 S Capital of Texas Hwy Suite 330 Austin, Texas 78704 [email protected]See details»
Lung Therapeutics (USA) Funding: $53.9M - medicalstartups.org
Dec 19, 2024 Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural …See details»
Lung Therapeutics, Inc. Raises $36 Million in Series C Financing to ...
Jun 10, 2019 The company’s lead drug, LTI-01, is in development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company’s second …See details»